Antiplaque Essential Oil In Vitro Plus In Vivo Test Requirement Urged By Pfizer
This article was originally published in The Rose Sheet
Executive Summary
The antigingivitis/antiplaque monograph should require that products containing a fixed combination of the essential oils menthol, thymol, methyl salicylate and eucalyptol be tested with both in vitro and in vivo test methods, Pfizer Consumer Healthcare maintains
You may also be interested in...
Antiplaque Claims Spectrum Outlined By WhiteHill
Products carrying antiplaque-only claims should be permitted in the OTC antigingivitis/antiplaque monograph, WhiteHill Oral Technologies states in Nov. 24 comments to FDA
Antiplaque Claims Spectrum Outlined By WhiteHill
Products carrying antiplaque-only claims should be permitted in the OTC antigingivitis/antiplaque monograph, WhiteHill Oral Technologies states in Nov. 24 comments to FDA
Combination Oral Health Care Product Safety Defended By Industry
Combination oral health care products should be permitted in the antigingivitis/antiplaque final monograph, according to the Joint Oral Care Task Group of the Consumer Healthcare Products Association and the Cosmetic, Toiletry and Fragrance Association